The buyer is not using this website to administer the notice.

To record your interest or obtain additional information or documents please find instructions within the Full Notice Text. (NOTE: Contract Award Notices and Prior Information Notices do not normally require a response)

Summary

OCID:
Published by:: NHS England
Authority ID:: AA20005
Publication date:: 19 August 2026
Deadline date:: -
Notice type:: Prior Information Notice
Has documents:: No
Has SPD:: No
Has Carbon Reduction Plan:: N/A

Abstract

This is an Intended Approach Notice to award contracts using the Most Suitable Provider (MSP) Process for of the provision of Specialised Paediatric whole-body MRI(WBMRI) Surveillance for Cancer Predisposing Syndromes across the following Lots: Lot 1: London & East of England Lot 2: Midlands Lot 3: North East Lot 4: Yorkshire Lot 5: North West Lot 6: South East Providers must be located in and deliver services from the defined geographical area(s) that they are interested in providing services to. Inherited cancer predisposition syndromes are genetic conditions that increase the risk of developing one or more types of cancer. This service is for three rare inherited cancer predisposition syndromes; Li-Fraumeni syndrome (LFS), constitutional mismatch repair deficiency syndrome (CMMRD) and rhabdoid tumour predisposition syndrome (RTPS). Published clinical guidelines for these conditions recommend the use of regular whole-body MRI (WBMRI) with the aim of detecting cancers at an early stage. The overall aim of WBMRI surveillance for children with cancer predisposing syndromes is to provide WBMRI screening for patients with LFS, CMMRD and RTPS. The provision of expanded capacity within these groups for WBMRI scanning aims to improve clinical care of individuals once an inherited cancer predisposition has been diagnosed. Providers will: • Provide, interpret and report WBMRI Scanning for the patient cohort described •Provide, interpret, and report brain MRI Scanning (the first one with contrast when possible) •Establish effective pathways with referring and relevant clinical services for referral, undertaking surveillance, timely communication and sharing of imaging results, and onward management where required. •Have established links and pathways with Regional Genetics Services to support referral, coordination of surveillance, communication of results and continuity of care. •Demonstrate expertise in the provision, interpretation and reporting of WBMRI, including access to radiologists and multidisciplinary review with experience in the management of patients with cancer predisposition syndromes. •Facilitate communication with referrers including consultant clinical geneticists •Have capacity to plan and undertake WBMRI under general anaesthetic if required •Have information governance processes that permit sharing clinical and imaging data across organisations involved with providing a cancer surveillance service, and collection of clinical outcome and monitoring data; •Engage positively with associated patient support groups. •Ensure clear communication with Genetics Services and patients, to support patients to make decisions on where to access screening. •Work collaboratively with other organisations e.g. within imaging networks, to provide scanning and reporting capacity and expertise to meet the needs of their population including transition between paediatric and adult services. •Operate appropriate Quality Assessment processes in accordance with CQC requirements and relevant national standards and guidance for MRI safety, quality assurance and reporting. •Provide facilities will be in line with NHS guidance on Facilities for diagnostic imaging and interventional radiology. •Support continued educational initiatives for non-genetics health If you believe your organisation can provide the full set of requirements, please register on the e-Tendering portal at https://health-family.force.com/s/Welcome against project reference C462662 to access the MSP documentation and submit your response. The deadline for submitting completed Expression of Interest Questionnaires and Declarations is

Full notice text

Prior information notice

This notice is for prior information only

Section I: Contracting authority

I.1) Name and addresses

NHS England

Wellington House, 133-135 Waterloo Rd

London

SE1 8UG

Contact person: Jessica Gaucher-Thompson

E-mail: jessica.gaucher-thompson@nhs.net

NUTS: UKI

Internet address(es)

Main address: https://www.england.nhs.uk/

Address of the buyer profile: https://www.england.nhs.uk/

I.3) Communication

Additional information can be obtained from the abovementioned address

Electronic communication requires the use of tools and devices that are not generally available. Unrestricted and full direct access to these tools and devices is possible, free of charge, at:

https://atamis-1928.my.site.com/s/Welcome

I.4) Type of the contracting authority

Body governed by public law

I.5) Main activity

Health

Section II: Object

II.1) Scope of the procurement

II.1.1) Title

Specialised Paediatric Whole-Body MRI Surveillance for Cancer Predisposing Syndromes

II.1.2) Main CPV code

85100000

II.1.3) Type of contract

Services

II.1.4) Short description

II.1.5) Estimated total value

Value excluding VAT: 525 525.00 GBP

II.1.6) Information about lots

This contract is divided into lots: Yes

II.2) Description

Lot No: 1

II.2.1) Title

Lot 1: London & East of England

II.2.2) Additional CPV code(s)

85100000

II.2.3) Place of performance

NUTS code:

UKH

UKI

II.2.4) Description of the procurement

Providers must be located in and deliver services from the defined geographical area(s) that they are interested in providing services to. Link to NHS England Regions: NHS England » Regional teams(https://www.england.nhs.uk/about/regional-area-teams/). If you believe your organisation can provide the full set of requirements, please register on the e-Tendering portal at https://health-family.force.com/s/Welcome against project reference C462662 to access the MSP documentation and submit your response. The deadline for submitting completed Expression of Interest Questionnaires and Declarations is 12pm, midday, on Thursday 17 September 2026. It is anticipated that provider assessments will be completed between September and October 2026. This is a Provider Selection Regime (PSR) intended approach notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act Regulations 2023 do not apply to this award. The intention is to award contracts using the Most Suitable Provider Process and the award decisions will be made by National Commissioning Group, Chaired by the NHS England National Director of Specialised Commissioning.

II.2.14) Additional information

This is a Provider Selection Regime (PSR) intended approach notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act Regulations 2023 do not apply to this award. The intention is to award contracts using the Most Suitable Provider Process and the award decisions will be made by National Commissioning Group, Chaired by the NHS England National Director of Specialised Commissioning.

Lot No: 2

II.2.1) Title

Lot 2: Midlands

II.2.2) Additional CPV code(s)

85100000

II.2.3) Place of performance

NUTS code:

UKF

UKG

II.2.4) Description of the procurement

II.2.14) Additional information

Lot No: 3

II.2.1) Title

Lot 3: North East

II.2.2) Additional CPV code(s)

85100000

II.2.3) Place of performance

NUTS code:

UKC

II.2.4) Description of the procurement

II.2.14) Additional information

Lot No: 4

II.2.1) Title

Lot 4: Yorkshire

II.2.2) Additional CPV code(s)

85100000

II.2.3) Place of performance

NUTS code:

UKE

II.2.4) Description of the procurement

II.2.14) Additional information

Lot No: 5

II.2.1) Title

Lot 5: North West

II.2.2) Additional CPV code(s)

85100000

II.2.3) Place of performance

NUTS code:

UKD

II.2.4) Description of the procurement

II.2.14) Additional information

Lot No: 6

II.2.1) Title

Lot 6: South East

II.2.2) Additional CPV code(s)

85100000

II.2.3) Place of performance

NUTS code:

UKJ

II.2.4) Description of the procurement

II.2.14) Additional information

II.3) Estimated date of publication of contract notice:

17/08/2026

Section IV: Procedure

IV.1) Description

IV.1.8) Information about Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes

Section VI: Complementary information

VI.3) Additional information

This is a Provider Selection Regime (PSR) intended approach notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. The Commissioner's assessment will be on a [pass/fail] basis. It is anticipated that provider assessments will be completed between September and October 2026. For the avoidance of doubt, the provisions of the Procurement Act Regulations 2023 do not apply to this award. The intention is to award contracts using the Most Suitable Provider Process and the award decisions will be made by National Commissioning Group, Chaired by the NHS England National Director of Specialised Commissioning.

VI.5) Date of dispatch of this notice

17/08/2026

Coding

Commodity categories

ID	Title	Parent category
85100000	Health services	Health and social work services

Delivery locations

ID	Description
100	UK - All

Alert region restrictions

The buyer has restricted the alert for this notice to suppliers based in the following regions.

ID	Description
There are no alert restrictions for this notice.

About the buyer

Main contact:: jessica.gaucher-thompson@nhs.net
Admin contact:: N/a
Technical contact:: N/a
Other contact:: N/a

Further information

Date	Details
No further information has been uploaded.

Specialised Paediatric Whole-Body MRI Surveillance for Cancer Predisposing Syndromes

Contents

Summary

Abstract

Full notice text

Prior information notice

Section I: Contracting authority

I.1) Name and addresses

I.3) Communication

I.4) Type of the contracting authority

I.5) Main activity

Section II: Object

II.1) Scope of the procurement

II.1.1) Title

II.1.2) Main CPV code

II.1.3) Type of contract

II.1.4) Short description

II.1.5) Estimated total value

II.1.6) Information about lots

II.2) Description

II.2.1) Title

II.2.2) Additional CPV code(s)

II.2.3) Place of performance

II.2.4) Description of the procurement

II.2.14) Additional information

II.2.1) Title

II.2.2) Additional CPV code(s)

II.2.3) Place of performance

II.2.4) Description of the procurement

II.2.14) Additional information

II.2.1) Title

II.2.2) Additional CPV code(s)

II.2.3) Place of performance

II.2.4) Description of the procurement

II.2.14) Additional information

II.2.1) Title

II.2.2) Additional CPV code(s)

II.2.3) Place of performance

II.2.4) Description of the procurement

II.2.14) Additional information

II.2.1) Title

II.2.2) Additional CPV code(s)

II.2.3) Place of performance

II.2.4) Description of the procurement

II.2.14) Additional information

II.2.1) Title

II.2.2) Additional CPV code(s)

II.2.3) Place of performance

II.2.4) Description of the procurement

II.2.14) Additional information

II.3) Estimated date of publication of contract notice:

Section IV: Procedure

IV.1) Description

IV.1.8) Information about Government Procurement Agreement (GPA)

Section VI: Complementary information

VI.3) Additional information

VI.5) Date of dispatch of this notice

Coding

Commodity categories

Delivery locations

Alert region restrictions

About the buyer

Further information